Search hospitals

>

Florida

>

Gainesville

University of Florida

Claim this profile

Gainesville, Florida 32607

Global Leader in Cancer

Global Leader in Brain Tumor

Conducts research for Solid Tumors

Conducts research for Breast Cancer

Conducts research for Type 1 Diabetes

1199 reported clinical trials

164 medical researchers

Photo of University of Florida in GainesvillePhoto of University of Florida in GainesvillePhoto of University of Florida in Gainesville

Summary

University of Florida is a medical facility located in Gainesville, Florida. This center is recognized for care of Cancer, Brain Tumor, Solid Tumors, Breast Cancer, Type 1 Diabetes and other specialties. University of Florida is involved with conducting 1,199 clinical trials across 1,792 conditions. There are 164 research doctors associated with this hospital, such as William Slayton, MD, Thomas J. George, Mustafa Ahmed, MD, and Elias Sayour, MD, PhD.

Area of expertise

1

Cancer

Global Leader

University of Florida has run 113 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage III
Stage I
2

Brain Tumor

Global Leader

University of Florida has run 84 trials for Brain Tumor. Some of their research focus areas include:

Stage IV
IDH positive
Stage I

Top PIs

Clinical Trials running at University of Florida

Breast Cancer

Cancer

Pancreatic Cancer

Lung Cancer

Ovarian Cancer

Breast cancer

Bladder Cancer

Testicular cancer

Small Cell Lung Cancer

Neuroblastoma

Image of trial facility.

Sacituzumab Govitecan + Pembrolizumab

for Triple Negative Breast Cancer

The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.

Recruiting

2 awards

Phase 3

6 criteria

Image of trial facility.

Low Dose Tamoxifen

for Breast Cancer

This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy to treat postmenopausal women with hormone-dependent breast cancer. Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer.

Recruiting

2 awards

Phase 3

8 criteria

Image of trial facility.

Mindfulness Approaches

for Living After Breast Cancer

NRG-CC015 is a prospective, randomized phase III clinical trial to evaluate the efficacy of two distinct digital approaches for delivering a mindfulness-based intervention: a live, instructor-led version delivered over Zoom (MAPs LO), and an app-based, self-paced version (MAPs App). Participants will include younger breast cancer survivors (BCS) who were diagnosed with breast cancer at or before age 50 years, have completed their primary cancer treatment (i.e., surgery, radiation, and/or chemotherapy) at least 6 months earlier, and report elevated depressive symptoms.

Recruiting

2 awards

Phase 3

5 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of Florida?

Where is University of Florida located?

Who should I call to ask about financial aid or insurance network?

What insurance does University of Florida accept?

What awards or recognition has University of Florida received?